Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Phytoplankton is used to support or treat free radical damage primarily due to its antioxidant properties, which are supported by some scientific evidence. Phytoplankton, especially marine microalgae such as Nannochloropsis and Tetraselmis, contain a range of bioactive compounds, including carotenoids (like astaxanthin and beta-carotene), phycocyanins, vitamins C and E, and polyphenols, all of which are recognized antioxidants. Several in vitro studies have demonstrated that extracts from marine phytoplankton can scavenge free radicals and reduce oxidative stress in cell models. For example, research published in peer-reviewed journals (e.g., Marine Drugs, 2012) has shown that phytoplankton-derived compounds inhibit reactive oxygen species (ROS) in cultured cells and can protect against oxidative damage. However, clinical evidence in humans is limited. Most studies are preclinical, and there is a lack of well-controlled human trials directly linking phytoplankton supplementation to reduced free radical damage or improved health outcomes. Thus, while the antioxidant content is established and laboratory studies are promising, more robust clinical research is needed to confirm efficacy in humans. The overall evidence rating is moderate, reflecting strong mechanistic rationale and preclinical data but limited human evidence.

More about Phytoplankton
More about Free Radical Damage

Other ingredients used for Free Radical Damage

Other health conditions supported by Phytoplankton

Products containing Phytoplankton